Evidence map›Paper›PMID 39358976›Full record

ArticleClinical physiology and functional imaging2025

The prognostic value of [

Nadide Mutlukoca Stern, Lars Tore Gyland Mikalsen, Svein Dueland, Anselm Schulz, Pål-Dag Line, Caroline Stokke, Harald Grut

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical physiology and functional imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The prognostic value of [Clinical physiology and functional imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadide Mutlukoca SternDepartment of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.
Lars Tore Gyland MikalsenDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Svein DuelandDepartment of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Anselm SchulzDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0000-0001-7406-5497
Pål-Dag LineInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Caroline StokkeDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Harald GrutDepartment of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.ORCID http://orcid.org/0000-0001-9271-8789

Funding

Oslo University HospitalVestre Viken Hospital Trust
6 · The paper itself

Abstract

introductionTo determine whether heterogeneity in colorectal liver metastases (CRLM)

methodsThe preoperative [

resultsTwenty-eight out of 40 patients who underwent LT for unresectable CRLM had liver metastases with uptake above liver background and were eligible for inclusion. Low MTV (p < 0.001) and dissimilarity

conclusionAlthough some texture parameters were able to significantly predict DFS and OS, MTV seems to be superior to predict both DFS and OS following LT for unresectable CRLM.

Indexed as

Colorectal NeoplasmsFluorodeoxyglucose F18Liver NeoplasmsLiver TransplantationPositron Emission Tomography Computed TomographyPredictive Value of TestsRadiopharmaceuticalsAdultAgedDisease-Free SurvivalFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsFluorodeoxyglucose F18Radiopharmaceuticalsliver tumourslong‐term survivalpatient selectionradiomicstumour heterogeneity

Identifiers

PMID39358976
PMCPMC11650445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.